PaperTrue

     恭喜清华大学电子工程系余佳东团队喜中ADVANCED MATERIALS(IF:25.8),购买服务为:优质润色 点击查看更多发表案例
以下是对 J IMMUNOTHER CANCER 杂志介绍 收藏
缩写名/全名
J IMMUNOTHER CANCER
Journal for ImmunoTherapy of Cancer
ISSN号 2051-1426
研究方向 -
影响因子 2015:0, 2016:0, 2017:8.374, 2018:8.676, 2019:9.913,
出版国家 UNITED STATES
出版周期
年文章数 326
出版年份 0
是否OA Yes
审稿周期(仅供参考)
录用比例
投稿链接 https://jitc.biomedcentral.com/submission-guidelines
投稿官网 https://jitc.biomedcentral.com/
h-index 36
CiteScore
CiteScoreSJRSNIPCiteScore排名
6.863.3371.416
学科分区排名
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q19 / 300
大类:Biochemistry, Genetics and Molecular Biology
小类:Molecular Medicine
Q111 / 165
大类:Medicine
小类:Immunology and Allergy
Q117 / 188
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q118 / 191
大类:Medicine
小类:Oncology
Q119 / 321
大类:Immunology and Microbiology
小类:Immunology
Q120 / 198

PubMed Central (PMC)链接 http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2051-1426%5BISSN%5D
中科院SCI期刊分区
( 2018年新版本)
大类学科小类学科Top期刊综述期刊
医学 1区1区3区
IMMUNOLOGY
免疫学
4区3区1区
ONCOLOGY
肿瘤学
4区1区2区
中科院SCI期刊分区
( 2020年新版本)
大类学科小类学科Top期刊综述期刊
医学 2区2区2区
ONCOLOGY
肿瘤学
1区2区3区
IMMUNOLOGY
免疫学
4区4区3区
  • 该杂志上中国学者近期发表的论文
  • 同领域相关期刊
中国学者近期发表的论文
1.HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1

Author: Chu-Yu Jing, Yi-Peng Fu, Yong Yi, Mei-Xia Zhang, Su-Su Zheng, Jin-Long Huang, Wei Gan, Xin Xu, Jia-Jia Lin, Juan Zhang, Shuang-Jian Qiu, Bo-Heng Zhang
Journal: Journal for ImmunoTherapy of Cancer, 2019, Vol.7, , DOI:10.1186/s40425-019-0554-8
    DOI
2.Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway

Author: Yipin Lv, Yongliang Zhao, Xianhua Wang, Na Chen, Fangyuan Mao, Yongsheng Teng, Tingting Wang, Liusheng Peng, Jinyu Zhang, Ping Cheng, Yugang Liu, Hui Kong, Weisan Chen, Chuanjie Hao, Bin Han, Qiang Ma, Quanming Zou, Jun Chen, Yuan Zhuang
Journal: Journal for ImmunoTherapy of Cancer, 2019, Vol.7, , DOI:10.1186/s40425-019-0530-3
    DOI
3.A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy

Author: Tongjuan Li, Yuanyuan Zhang, Dan Peng, Xia Mao, Xiaoxi Zhou, Jianfeng Zhou
Journal: Journal for ImmunoTherapy of Cancer, 2019, Vol.7, , DOI:10.1186/s40425-019-0529-9
    DOI
4.Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

Author: Hang-Ping Yao, Liang Feng, Sreedhar Reddy Suthe, Ling-Hui Chen, Tian-Hao Weng, Chen-Yu Hu, Eun Sung Jun, Zhi-Gang Wu, Wei-Lin Wang, Song Cheol Kim, Xiang-Min Tong, Ming-Hai Wang
Journal: Journal for ImmunoTherapy of Cancer, 2019, Vol.7, , DOI:10.1186/s40425-019-0525-0
    DOI
5.Cancer-cell-secreted CXCL11 promoted CD8<Superscript>+</Superscript> T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC

Author: Qun Gao, Shumin Wang, Xinfeng Chen, Shaoyan Cheng, Zhen Zhang, Feng Li, Lan Huang, Yang Yang, Bin Zhou, Dongli Yue, Dan Wang, Ling Cao, Nomathamsanqa Resegofetse Maimela, Bin Zhang, Jane Yu, Liping Wang, Yi Zhang
Journal: Journal for ImmunoTherapy of Cancer, 2019, Vol.7, , DOI:10.1186/s40425-019-0511-6
    DOI
6.Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Author: Mohammed Alnaggar, Yan Xu, Jingxia Li, Junyi He, Jibing Chen, Man Li, Qingling Wu, Li Lin, Yingqing Liang, Xiaohua Wang, Jiawei Li, Yi Hu, Yan Chen, Kecheng Xu, Yangzhe Wu, Zhinan Yin
Journal: Journal for ImmunoTherapy of Cancer, 2019, Vol.7, , DOI:10.1186/s40425-019-0501-8
    DOI
7.TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways

Author: Yuxue Jiang, Jintong Chen, Enguang Bi, Yinghua Zhao, Tianxue Qin, Yiming Wang, Alison Wang, Sujun Gao, Qing Yi, Siqing Wang
Journal: Journal for ImmunoTherapy of Cancer, 2019, Vol.7, , DOI:10.1186/s40425-018-0494-8
    DOI
8.Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients

Author: Bin Zhao, Hong Zhao, Jiaxin Zhao
Journal: Journal for ImmunoTherapy of Cancer, 2019, Vol.7, , DOI:10.1186/s40425-018-0487-7
    DOI
9.Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis

Author: Yixin Zhou, Chen Chen, Xuanye Zhang, Sha Fu, Cong Xue, Yuxiang Ma, Wenfeng Fang, Yunpeng Yang, Xue Hou, Yan Huang, Hongyun Zhao, Shaodong Hong, Li Zhang
Journal: Journal for ImmunoTherapy of Cancer, 2018, Vol.6, , DOI:10.1186/s40425-018-0477-9
    DOI
10.1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis

Author: Yutao Yan, Lei Chang, Hongzhe Tian, Lu Wang, Yawei Zhang, Tao Yang, Guohao Li, Weifeng Hu, Kavita Shah, Gang Chen, Yonglian Guo
Journal: Journal for ImmunoTherapy of Cancer, 2018, Vol.6, , DOI:10.1186/s40425-018-0466-z
    DOI
同类著名期刊名称 h-index CiteScore
CA-A CANCER JOURNAL FOR CLINICIANS144160.19
NEW ENGLAND JOURNAL OF MEDICINE93316.10
NATURE REVIEWS DRUG DISCOVERY2899.90
LANCET70010.28
Nature Reviews Clinical Oncology1278.04
NATURE REVIEWS CANCER39623.23
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION6226.98
Nature Reviews Disease Primers4825.88
World Psychiatry616.95
World Psychiatry708.13
中科院JCR同大类学科的热搜期刊 浏览次数
MEDICINE300060
CANCER RESEARCH165884
Molecular Medicine Reports164664
International Journal of Nanomedicine164432
CANCER LETTERS159477
JOURNAL OF ETHNOPHARMACOLOGY141676
BIOMEDICINE & PHARMACOTHERAPY140567
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY135930
Theranostics135909
International Journal of Environmental Research and Public Health133597